Evidence map›Paper›PMID 36831043›Full record

ReviewBiomedicines2023

Advanced Graft Development Approaches for ACL Reconstruction or Regeneration.

Olga Urbanek, Maryla Moczulska-Heljak, Mikołaj Wróbel, Andrzej Mioduszewski, Dorota Kołbuk

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Embroidered Silk Fibroin Scaffolds for ACL Tissue Engineering.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Olga UrbanekInstitute of Fundamental Technological Research, Polish Academy of Sciences, Adolfa Pawińskiego 5b, 02-106 Warsaw, Poland.
Maryla Moczulska-HeljakInstitute of Fundamental Technological Research, Polish Academy of Sciences, Adolfa Pawińskiego 5b, 02-106 Warsaw, Poland.
Mikołaj WróbelOrtopedika-Centre for Specialized Surgery, Modlińska 310/312, 03-152 Warsaw, Poland.ORCID 0000-0002-0777-5349
Andrzej MioduszewskiOrtopedika-Centre for Specialized Surgery, Modlińska 310/312, 03-152 Warsaw, Poland.
Dorota KołbukInstitute of Fundamental Technological Research, Polish Academy of Sciences, Adolfa Pawińskiego 5b, 02-106 Warsaw, Poland.ORCID 0000-0001-9651-7087
Institute of Fundamental Technological Research · PL

Funding

EEA and Norway Grants NOR/SGS/BioLigaMed/0272/2020.
6 · The paper itself

Abstract

The Anterior Cruciate Ligament (ACL) is one of the major knee ligaments, one which is greatly exposed to injuries. According to the British National Health Society, ACL tears represent around 40% of all knee injuries. The number of ACL injuries has increased rapidly over the past ten years, especially in people from 26-30 years of age. We present a brief background in currently used ACL treatment strategies with a description of surgical reconstruction techniques. According to the well-established method, the PubMed database was then analyzed to scaffold preparation methods and materials. The number of publications and clinical trials over the last almost 30 years were analyzed to determine trends in ACL graft development. Finally, we described selected ACL scaffold development publications of engineering, medical, and business interest. The systematic PubMed database analysis indicated a high interest in collagen for the purpose of ACL graft development, an increased interest in hybrid grafts, a numerical balance in the development of biodegradable and nonbiodegradable grafts, and a low number of clinical trials. The investigation of selected publications indicated that only a few suggest a real possibility of creating healthy tissue. At the same time, many of them focus on specific details and fundamental science. Grafts exhibit a wide range of mechanical properties, mostly because of polymer types and graft morphology. Moreover, most of the research ends at the in vitro stage, using non-certificated polymers, thus requiring a long time before the medical device can be placed on the market. In addition to scientific concerns, official regulations limit the immediate introduction of artificial grafts onto the market.

Indexed as

biomaterialimplantligamentnatural polymerregenerationscaffoldsynthetic polymertissue engineering

Identifiers

PMID36831043
PMCPMC9953332
OpenAlexW4319964779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.